The Insulin Paradox: How GLP-1 Drugs Reduce Belly Fat and Heart Risk
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
The Insulin Paradox: How GLP-1 Drugs Reduce Belly Fat and Heart Risk
-
Narrated by:
-
By:
About this listen
GLP-1 drugs seem paradoxical: they enhance insulin action yet shrink dangerous belly fat. The explanation lies in restoring normal insulin timing, reducing chronic insulin exposure, and reversing fat “spillover” from liver to abdomen. Real patient cases show rapid visceral fat loss alongside smoother glucose profiles and lower cardiovascular risk.
See blog for more details
All VAT TRAP Podcasts
No reviews yet